Shares of Merck & Co. Inc.
and Pfizer Inc.
rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average
components, but not enough to lift the Dow into positive territory. Merck’s stock rose 2.7% after profit and revenue beats and raised outlook, and the implied price gain suggests a 15-point boost to the Dow’s price. Pfizer shares climbed 3.2% after an earnings beat and raised outlook, with the implied price gain adding about 8 points to the Dow. Despite the combined boost to the Dow of 23 points, but Dow futures
fell 42 points, as 20 of 30 components traded lower ahead of the open.
Go to Source